yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38867820-299970BF-1A33-4B2A-934A-A7442956C51A
Q38867820-299970BF-1A33-4B2A-934A-A7442956C51A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38867820-299970BF-1A33-4B2A-934A-A7442956C51A
Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.
P2860
Q38867820-299970BF-1A33-4B2A-934A-A7442956C51A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38867820-299970BF-1A33-4B2A-934A-A7442956C51A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e7509aff60a5b2f278183cdc650c1820164eeb4
P2860
Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.